Apalutamide 60mg tablets
NHS hospitals in England used £107,995,355 of indicative cost of Apalutamide 60mg tablets in the 12 months to July 2026, about 0.4% of all hospital medicines spend. That is down 19.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Apalutamide 60mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Apalutamide 60mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Nottingham University Hospitals Trust | £7,520,211 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £6,850,452 |
| Oxford University Hospitals Nhs Ft | £5,118,577 |
| South Tyneside And Sunderland Nhs Ft | £4,984,554 |
| University Hospital Southampton Nhs Ft | £4,056,027 |
| Gloucestershire Hpls Nhs Foundation Trst | £3,878,909 |
| The Clatterbridge Cancer Centre Nhs Ft | £3,552,795 |
| Sheffield Teaching Hospitals Nhs Trust | £3,382,530 |
| United Lincolnshire Hospitals Nhs Trust | £3,018,089 |
| Portsmouth Hospitals Nhs Trust | £3,001,684 |
The primary-care picture
Apalutamide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Apalutamide medicine page.